MedPath

TRINTELLIX

TRINTELLIX

Approved
DIN Number

02432943

Drug Class

Human

Market Date

Oct 28, 2014

Company
HC

Lundbeck Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02432943
AIG Number0156170004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AX26 VORTIOXETINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.04.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

VORTIOXETINE (VORTIOXETINE HYDROBROMIDE)Active
Strength: 20 MG
Monograph: VORTIOXETINE (VORTIOXETINE HYDROBROMIDE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.